Skip to main content

MoneyWorks4Me

Anuh Pharma - Quaterly Results

31 Oct 2026 Evaluate
A slight decline in the revenue of Rs. 1852.41 millions was seen for the September 2026 quarter as against Rs. 1858.83 millions during year-ago period.A good growth in profit of 47.33% reported to Rs. 112.13  millions over Rs. 76.11 millions of corresponding previous quarter.The company reported a good operating profit of 175.52 millions compared to 128.57 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 1852.41 1858.83 -0.35 3790.51 3723.62 1.80 7716.57 6615.15 16.65
Other Income 6.08 9.78 -37.83 36.85 43.66 -15.60 43.56 94.55 -53.93
PBIDT 175.52 128.57 36.52 369.17 265.36 39.12 660.76 703.64 -6.09
Interest 0.52 0.76 -31.58 0.55 2.87 -80.84 4.72 6.19 -23.75
PBDT 175.00 127.81 36.92 368.62 262.49 40.43 656.04 697.45 -5.94
Depreciation 24.52 28.62 -14.33 48.85 53.77 -9.15 113.82 87.39 30.24
PBT 150.48 99.19 51.71 319.77 208.72 53.21 542.22 610.06 -11.12
TAX 38.35 23.08 66.16 93.38 49.60 88.27 131.75 136.53 -3.50
Deferred Tax -0.99 -4.92 -79.88 12.72 -3.30 -485.45 -18.44 -16.52 11.62
PAT 112.13 76.11 47.33 226.39 159.12 42.28 410.47 473.53 -13.32
Equity 501.12 501.12 0.00 501.12 501.12 0.00 501.12 250.56 100.00
PBIDTM(%) 9.48 6.92 36.99 9.74 7.13 36.67 8.56 10.64 -19.50
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..